Latest News and Press Releases

ROCKVILLE, Md., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the three month period ended September 27, 2008. The...

ROCKVILLE, Md., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...

ROCKVILLE, Md., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its third quarter 2008 financial results on Thursday, November 6, 2008,...

ROCKVILLE, Md., Sept. 9, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the National Institute of Allergy and Infectious Diseases (NIAID), one of the National...

ROCKVILLE, Md., Aug. 7, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 28, 2008. The Company...

ROCKVILLE, Md., Aug. 4, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of an arbitration proceeding against Inhibitex, Inc., effective August 1, 2008....

ROCKVILLE, Md., July 29, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2008 financial results on Thursday, August 7, 2008, after...

ROCKVILLE, Md., July 23, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive interim results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...

ROCKVILLE, Md., June 3, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has received a $2.5 million payment from Fresenius USA Manufacturing, Inc. (Fresenius) for the successful...

ROCKVILLE, Md., May 8, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 29, 2008. The Company...